Dexmedetomidine Accord 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
IB/0011 
C.I.2.a - Change in the SPC, Labelling or PL of a 
24/01/2023 
SmPC and PL 
To update section 4.4 of the SmPC to add a new warning 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
on mortality in ICU patients ≤ 65 years old, to align to 
reference product. Package leaflet has been updated 
accordingly. 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
IB/0009 
B.II.b.3.a - Change in the manufacturing process of 
24/11/2022 
n/a 
the finished or intermediate product - Minor change 
in the manufacturing process 
IB/0010 
C.I.11.z - Introduction of, or change(s) to, the 
18/11/2022 
n/a 
obligations and conditions of a marketing 
authorisation, including the RMP - Other variation 
IA/0008 
B.II.b.2.a - Change to importer, batch release 
23/08/2022 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IB/0007 
C.I.2.a - Change in the SPC, Labelling or PL of a 
08/04/2022 
09/11/2022 
SmPC and PL 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
IA/0006 
A.7 - Administrative change - Deletion of 
02/02/2022 
09/11/2022 
Annex II and 
manufacturing sites 
PL 
IAIN/0005 
B.II.e.6.a - Change in any part of the (primary) 
02/11/2021 
09/11/2022 
SmPC 
packaging material not in contact with the finished 
product formulation - Change that affects the 
product information 
IB/0004 
B.II.b.4.z - Change in the batch size (including batch 
24/06/2021 
n/a 
size ranges) of the finished product - Other variation 
Page 2/4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0003/G 
This was an application for a group of variations. 
18/02/2021 
n/a 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.1.b - Replacement or addition of a 
manufacturing site for the FP - Primary packaging 
site 
B.II.b.1.f - Replacement or addition of a 
manufacturing site for part or all of the 
manufacturing process of the FP - Site where any 
manufacturing operation(s) take place, except batch 
release, batch control, and secondary packaging, for 
sterile medicinal products (including those that are 
aseptically manufactured) excluding biological/ 
immunological medicinal products 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.II.b.4.a - Change in the batch size (including batch 
size ranges) of the finished product - Up to 10-fold 
compared to the originally approved batch size 
IB/0002 
B.II.b.4.z - Change in the batch size (including batch 
19/08/2020 
n/a 
size ranges) of the finished product - Other variation 
IAIN/0001 
B.II.e.6.a - Change in any part of the (primary) 
29/06/2020 
17/06/2021 
SmPC 
packaging material not in contact with the finished 
product formulation - Change that affects the 
product information 
Page 3/4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 4/4 
 
 
 
 
 
 
 
